Lack of funding for startup ventures is stunting the growth of Colorado's biosciences sector, industry leaders and entrepreneurs said.
Promising drug treatments and medical products are being developed more slowly or abandoned and some small companies are closing because of lack of capital, they said.
"There isn't enough capital coming in to fund all of the good deals," said Denise Brown, interim executive director of the Colorado BioScience Association. "Our whole pipeline of innovation is going to be stymied unless we come up with a new model."
The problem is national, even global, in scope. But it's being felt acutely in Colorado's biosciences community of mostly small companies served by a dwindling handful of local venture-capital firms.
To read the full, original article click on this link: Lack of venture capital stymies Colorado startups - The Denver Post
Author: By Greg Griffin The Denver Post
